SCOPUS 정보 검색 플랫폼

Pharmaceutical Research

Volumn 18, Issue 3, 2001, Pages 394-397

Variability in the bioavailability of phenytoin capsules in males and females

(7) Meyer, M C a Straughn, A B a Mhatre, R M b Shah, V P b Chen, M L b Williams, R L b,c Lesko, L J b

a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER (United States)

b CENTER FOR DRUG EVALUATION AND RESEARCH (United States)

c UNITED STATES PHARMACOPEIA (United States)

Author keywords

Bioavailability; Gender; Human; Menstrual cycle; Pharmacokinetics; Phenytoin

Indexed keywords

PHENYTOIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HUMAN; MALE; MENSTRUAL CYCLE; NORMAL HUMAN; PRIORITY JOURNAL; SEX DIFFERENCE;

ADULT; ANTICONVULSANTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CAPSULES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; FEMALE; HUMANS; MALE; PHENYTOIN; SEX CHARACTERISTICS; THERAPEUTIC EQUIVALENCY;

EID: 0034955449 PISSN: 07248741 EISSN: None Source Type: Journal
DOI: 10.1023/A:1011075502215 Document Type: Article

Times cited : (22)

References (13)

1
- 0004713950
- Center for Drug Evaluation and Research (CDER), Rockville, MD, August
- (1999) BA and BE Studies for Orally Administered Drug Products-General Considerations. Draft Guidance for Industry, Food and Drug Administration

2
- 33750938651
- Guidance for Industry, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Rockville, MD, March
- (1994) Phenytoin/Phenytoin Sodium (capsules, tablets, suspension) In Vivo Bioequivalence and In Vitro Dissolution Testing

3
- 0004061014
- Marcel Dekker, New York
- (1975) Pharmacokinetics
- Gibaldi, M.¹ Perrier, D.²

4
- 0023615056
- A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability
- (1987) J. Pharmacokin. Biopharm. , vol.15 , pp. 657-680
- Schuirmann, D.J.¹

5
- 0003922017
- Draft Guidance for Industry, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Rockville, MD, August
- (1999) Average, Population, and Individual Bioequivalence Approaches to Establishing Bioequivalence

6
- 0029965765
- The assessment of individual and population bioequivalence
- (1996) J. Pharmacokinet. Biopharm. , vol.6 , pp. 1-14
- Chinchilli, V.M.¹

7
- 0029744834
- Design and analysis of intra-subject variability in cross-over experiments
- (1996) Stat. Med. , vol.15 , pp. 1619-1634
- Chinchilli, V.M.¹ Esinhart, J.D.²

8
- 0000722255
- Approximate confidence limits on the mean of X+Y where X and Y are two-tabled independent random variables
- (1974) J. Amer. Stat. Assoc. , vol.69 , pp. 789-794
- Howe, G.¹

9
- 0002068388
- Confidence intervals on linear combinations of variance components that are unrestricted in sign
- (1990) J. Stat. Comp. Sim. , vol.35 , pp. 135-143
- Ting, N.¹ Burdick, R.K.² Graybill, F.A.³ Jeyaratnam, S.⁴ Lu, T.F.C.⁵

10
- 0034735561
- A small-sample confidence interval approach to assess individual bioequivalence
- in press
- Stat. Med.
- Hyslop, T.¹ Hsuan, F.² Holder, D.J.³

11
- 0032440352
- (1998) Epilepsia , vol.39 , pp. 1317-1323
- Mamiya, K.¹ Ieiri, I.² Shimamoto, J.³ Yukawa, E.⁴ Imai, J.⁵ Ninomiya, H.⁶ Yamada, H.⁷ Otsubo, K.⁸ Higuchi, S.⁹ Tashiro, N.¹⁰

12
- 0021261410
- Phenytoin pharmacokinetics in catamenial epilepsy
- (1984) Neurology , vol.34 , pp. 959-961
- Shavit, G.¹ Lerman, P.² Korczyn, A.D.³ Bechar, M.⁴ Gitter, S.⁵

13
- 0023934810
- Phenytoin levels in catamenial epilepsy
- (1988) Epilepsia , vol.292 , pp. 155-158
- Kumar, N.¹ Behari, M.² Ahuja, G.K.³ Jaikhani, B.L.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.